Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, December 18, 2024
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Biotech
AstraZeneca to Acquire Alexion
Life Sciences Times
-
December 12, 2020
0
Real Estate
Life Sciences Boom: With 85 Active Life Science Tenants Requiring 3.9 Million SF, Greater Boston Life Sciences Market is Hot
Life Sciences Times
-
December 12, 2020
0
Real Estate
Harrison Street and Partners Sell Three Life Sciences Properties in Cambridge Discovery Park for $720 Million
Life Sciences Times
-
December 12, 2020
0
Biotech
Trailblazers: Vertex CEO Reshma Kewalramani on Leadership, STEM, Diversity, Inclusion and Medicine on Chai With Manju
Life Sciences Times
-
December 11, 2020
0
Pharma
Trastuzumab Deruxtecan Recommended for Approval in the EU by CHMP for HER2 Positive Metastatic Breast Cancer
Life Sciences Times
-
December 11, 2020
0
Venture Capital
ScienceMedia Strikes Investment Deal with Decathlon Capital to Accelerate Clinical Education Platform
Life Sciences Times
-
December 11, 2020
0
Real Estate
Brooks Rehabilitation to Open a Rehabilitation Hospital in Lake Nona
Life Sciences Times
-
December 11, 2020
0
Public Health
Tychan to Start COVID-19 Phase 3 Clinical Trial For Novel Monoclonal Antibody TY027
Life Sciences Times
-
December 11, 2020
0
Biotech
Cell Isolation/ Separation Market Worth $15.0 Billion by 2025
Life Sciences Times
-
December 11, 2020
0
Medtech
Roche teams up with Diabeloop to advance the management of insulin pump therapy
Life Sciences Times
-
December 11, 2020
0
1
...
569
570
571
572
Page 570 of 572
Most Popular
VectorY Strengthens Leadership Team with Appointment of Jim Scibetta as New CEO
December 16, 2024
MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas
December 16, 2024
Pleno, Inc. Appoints Dr. Vik Vaz, M.D. as Chief Executive Officer & President to Drive Commercial Growth After Closing $25M Series B Funding
December 12, 2024
Turn Therapeutics Secures $75 Million Investment Commitment Tied to Public Listing
December 12, 2024
Load more
Recent Comments
Recent Comments